Upadacitinib Impurity 15

SZ目录编号:	SZ-U005017
CAS 号	NA
分子式	C17H19F3N6O
分子量	380.4
投资状态	Custom Synthesis

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

化学名称: (3R,4S)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide compound with (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide (1:1)

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

微笑: CC[C@@H](CN(C(NCC(F)(F)F)=O)C1)[C@@H]1C2=CN=C3N2C(C=CN4)=C4N=C3.CC[C@H](CN(C(NCC(F)(F)F)=O)C5)[C@H]5C6=CN=C7N6C(C=CN8)=C8N=C7

Upadacitinib Impurity 15 is chemically (3R,4S)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide compound with (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide (1:1). Upadacitinib Impurity 15 is supplied with detailed characterization data compliant with regulatory guideline. Upadacitinib Impurity 15 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Upadacitinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Upadacitinib Impurity 15

Contacts

Our Locations